Funding Our DIPG Research Efforts
Federal grant money is scarce for “rare pediatric” diseases. Our progress in understanding DIPG has been funded primarily by private foundations, including:
Thanks to generous philanthropic support, Javad Nazarian, PhD and a multidisciplinary team of experts at Children's National have been involved in generating the complete protein profile of CSF from children with brain tumors. And, a recent grant from the Rally Foundation will enable Dr. Nazarian and his team to study potential DIPG treatments in mouse models.
At the same time, we’re also hoping to secure a three-year grant that will enable our DIPG research team to:
- Create cells and avatar murine models that represent unique genomic subtypes
- Apply liquid biopsy to measure tumor response to treatment
- Conduct proteogenomic studies
- Test novel therapeutics
- Share our findings and advance the entire field of neuro-oncology
We believe the DIPG-focused team at Children’s Research Institute is poised to bring novel solutions, and ultimately improved outcomes, to DIPG patients around the world.